This contribution provides a window into the study of a densovirus called CpDV infecting Culex pipiens 33 mosquitoes. The originality of the study lies in the fact that CpDV, a DNA virus, was to date almost 34 unstudied, its interaction with its hosts and its transmission mode were unknown. Considering that all 35 Cx. pipiens are infected with Wolbachia, we studied the influence of this bacterial endosymbiont on 36 CpDV density and transmission. Although Wolbachia-RNA virus interactions, especially in non-native 37 Wolbachia-host associations have been widely studied, Wolbachia-DNA virus interactions were rarely 38 investigated.
Introduction
transmission (Ebert, 2013) . Transmission modes have long been investigated in many symbiotic systems 144 especially to understand their impact on virulence evolution (Ewald, 1983 (Ewald, , 1987 Alizon et al., 2009;  145 Cressler et al., 2016; Le Clec'h et al., 2017) . Empirical studies mostly showed that increased horizontal 146 transmission led to increased virulence, while dominance of vertical transmission mode mostly reduced 147 the virulence [reviewed in (Cressler et al., 2016) ]. Therefore transmission modes can have a major 148 impact on the dynamics of virus infection, their persistence and spread in populations.
150
To understand CpDV infection dynamics, especially its maintenance through generations, we 151 investigated the ability of Cx. pipiens mosquitoes to transmit CpDV vertically. Cx. pipiens are all 152 naturally infected with Wolbachia strains belonging to one of the five genetically distinct phylogenetic 153 group wPipI to wPipIV (Atyame et al. 2011 ). These wPip strains induce a wide diversity of cytoplasmic 154 incompatibility phenotypes in their mosquito host (Atyame et al. 2014) . In addition to their ability to 155 manipulate host reproduction to benefit their own vertical transmission (Stouthamer et al., 1999; Werren 156 et al., 2008; Sicard et al., 2014) , Wolbachia are also known to interact with several of their hosts' viruses 157 (Hedges et al., 2008; Teixeira et al., 2008; Zug and Hammerstein, 2014) . While putative difference in 158 protective ability between the wPip groups identified in Cx. pipiens has not yet been investigated, a 159 general protection by wPip has been shown against West Nile Virus infection (Micieli and Glaser, 2014) .
160
To date, no Wolbachia-mediated "protection" against DNA viruses have been shown in any insects.
161
Contrarily, one study demonstrate that Wolbachia makes their lepidopteran host more susceptible 162 against a Baculovirus (Graham et al., 2012) .
164
We thus examined the influence of Wolbachia on CpDV density and vertical transmission. To do that, 165 we monitored CpDV density and location in the ovaries and eggs, and then quantified its vertical CpDV was always present, along with Wolbachia, in the ovaries of females from ten laboratory lines 175 tested by qPCR and its amount varied between different lines (glm, df=13, dev=82.448, p<0 .001, Fig.   176 1). Only two pools of ovaries -one from Ich13 and another from Ich09 line-over 50 pools tested were 177 CpDV negative. We did not detect any statistically significant effect of Wolbachia amount (glm, df=1, 178 dev=0.007, p= 0.967, Fig. 1A 
183
To confirm the presence of virus particles -and not only of the viral genome (i.e. as detected by qPCR)-184 and to investigate their localization in the ovaries, we dissected ovaries from 6 days old Harash females 185 and performed immunolabelling of CpDV using an anti-capsid antibody for confocal observation ( Fig.   186 2 and Supplementary Fig. 1 ). The labelling of CpDV was mainly observed in follicular cells surrounding 187 the follicles ( Fig. 2A -B-C) and occasionally in some muscle cells of the sheath enclosing the ovariole 188 ( Fig. 2D ). In both cell types, the labelling is mainly nuclear with some dots present in the cytoplasm of 189 follicular cells ( Fig. 2B to E). Within the follicles, the labelling of CpDV in the nurse cells was not as 190 apparent and rather similar to the background immunofluorescence ( Fig. 2D -E). Although we cannot 191 entirely exclude a lack of permeability and accessibility of the nurse cells to the antibodies, a clear 192 labelling was nevertheless observed in a well-defined area of the nucleus of the oocyte ( Fig. 2E 
196
To examine the CpDV replication, which takes place in the nucleus, we prepared ultrathin sections of 197 ovaries and analyzed the nuclear ultrastructure with transmission electron microscopy (TEM) (Fig. 3 ).
198
Although no unequivocal densonucleosis was observed, follicular and nurse cells showed hypertrophied nuclei (Fig. 3A and G) . Intranuclear structures that could be interpreted as viral factories were observed 
206
Same experiments were performed on freshly laid dechorionated eggs from Harash females ( Fig. 4 ).
207
Immunolocalization of CpDV and DAPI staining of Wolbachia cells at early stage of the embryo 208 development showed a Wolbachia localization especially in the poles, and a CpDV localization both 209 inside and in the periphery of the eggs suggesting no co-localization of these two ( Fig. 4A , Top Panel).
210
At the syncytial blastoderm stage, CpDV were co-localized with the nuclei, presumably starting viral 211 replication ( Fig. 4A , Bottom Panel). Wolbachia were easily detected in the cytoplasm in the ultrathin 212 sections of fertilized eggs even at an early stage of development ( Fig. 4C ). However, at the early stage 213 of development nuclei were rare, meaning CpDV could only be observed in the cytoplasm where the 214 ribosomes are also present ( Fig. 4C ). As ribosomes and CpDV have the same diameter, it is not possible 215 to firmly distinguish them ( Fig. 4C ).
217

Effect of infection with distinct Wolbachia strains on CpDV amount in ovaries 218
To assess the effect of Wolbachia (strains and density) on the amount on CpDV in the ovaries, we have 219 established mosquito lines, with help of a backcrossing protocol, with the same host nuclear genetic 220 background but different Wolbachia strains (BcTunis, Slab genetic background harbouring wPip I from 221 Tunis line; BcHarash, Slab genetic background harbouring wPip IV from Harash line, Table 1 ). We then 222 quantified the amount of Wolbachia and CpDV in these lines as well as in Harash, Tunis and Slab lines 223 (Fig. 5) . Wolbachia amount in the ovaries was not significantly different between the Cx. pipiens lines 224 no matter what the Wolbachia strain and host genetic background were (Wolbachia strain: glm, df=2, 225 dev=17.703, p=0.875; host genetic background: df=1 dev=0.034, p=0.981, Fig. 5A ). Indeed, there was 226 no significant effect of the Wolbachia amount in the ovaries on CpDV density (lme, dev=0.001, df=1, p=0.9). However, Wolbachia strain (i.e. the genotype) infecting the mosquito lines explained a 228 significant part of the variance in the CpDV amount in the ovaries (lme, dev=12.236, df=1, p<0.001, 
244
Effect of Wolbachia curing by tetracycline on the amount of CpDV in ovaries 245
As all the Cx. pipiens isofemale lines were stably infected with wPip (Wo+), to test the effect of the 246 Wolbachia absence on CpDV presence and vertical transmission, we treated our Slab, BcHarash, and
247
BcTunis lines, all having the same genetic background, with tetracycline (TC) for three generations to 248 cure Wolbachia. We quantified Wolbachia and CpDV in dissected ovaries and carcasses of Wo+ (before 249 TC treatment) and Wo-females (after TC treatment), as well as females during the 1 st and 3 rd generation 250 of TC treatment (Fig. 6 ). There was no significant change between 1 st and 3 rd generations in terms of 251 CpDV amount (t = -0.643, df = 25.918, p-value = 0.525, Fig. 6B ). We thus grouped them together in a 252 "TC treatment" group for further statistical analyses and figures.
254
Prior to tetracycline treatment Wolbachia were found in higher density in the ovaries compared to the 255 carcasses (Wilcoxon rank sum test, W= 225, p<0.001; Fig. 6A ). By the end of the third generation of 256 tetracycline treatment, as expected, Wolbachia totally disappeared both from the ovaries and the 257 carcasses ( Fig. 6A ).
259
In non-treated Wo+ females, higher amount of CpDV were measured in ovaries compared to carcasses 260 (Wilcoxon rank sum test, W = 168, p = 0.021, Fig. 6B ). In the carcasses, TC treatment did not cause 261 any significant effects on CpDV amount ( Fig. 6B 290 gambiae densovirus (Brevidensovirus) have been shown to reach high densities in ovaries of their hosts 291 while they were also able to infect other host tissues (Ren et al., 2008; Suzuki et al., 2014; Xu et al., 292 2014).
294
The presence of CpDV capsids in the ovaries and eggs highlighted the possibility of vertical transovarial 295 transmission. Transmission mechanisms of densoviruses are generally thought to be horizontal causing 296 epizootics (Tijssen et al., 2016) . Nevertheless, vertical transmission has been shown both for some 297 ambidensoviruses and brevidensoviruses. Interestingly, ambidensoviruses with different vertical 298 transmission rates had different types of symbiotic interactions: while the 100% vertically transmitted 299 ambidensovirus of H. armigera is mutualistic (Xu et al., 2014) , the Myzus persicae densovirus which is 300 transmitted to 30-40% of the offspring has been shown to affect its hosts adversely (Van Munster et al., 301 2003) . In mosquitoes experimentally infected with brevidensoviruses, the vertical transmission ranged 302 between 28 to 62%: i) for Ae. albopictus densovirus, the vertical transmission rate ranged between 28-303 55% depending on the virus titer in parental females (Barreau et al., 1997) ; ii) for Ae. aegypti densovirus 304 vertical transmission ranged from 42% to 62% depending on the timing of the horizontal infection of 305 the larvae (the larvae that were infected during L3 stage transmitted the virus less, as they became adults, 306 than the larvae infected during L1 stage) (Suchman et al., 2006) , and iii) for A. gambiae densovirus 307 vertical transmission was detected in 28% of larval offspring (Ren et al., 2008) . We showed that CpDV 
384
All the mosquito lines used in this study ( Supplementary Table 1 ) have been maintained in insectary 385 conditions (at 25 ± 2 °C and 75 ± 2% relative humidity and a 12:12 h photoperiod). During larval stage, 386 they have been fed with a mixture of shrimp powder and rabbit pellets. Adults have been kept in 65 dm 3 387 cages and have been fed with a honey solution. Females were fed weekly with turkey blood using a 388 Hemotek membrane feeding system (Discovery Workshops, United Kingdom).
390
Backcrosses
To test the effect of the Wolbachia genetic differences on CpDV amount and their vertical transmission,
392
we introduced the cytoplasm of Tunis and Harash lines, along with their respective wPip strains, into 393 the Slab nuclear background as described by Duron et al (Duron et al., 2012) . With this backcrossing 394 protocol we have established BcTunis and BcHarash lines with the same genetic background (over 97% 395 of genome replacement of the original lines by Slab nuclear genome is estimated) and different 396 Wolbachia types (wPipI and wPipIV respectively, Table 1 ). wPip types were verified with a PCR/RFLP 397 test on pool of larvae using pk1 primers as previously described (Altinli et al., 2018) .
399
Wolbachia free lines 400 BcTunis, Slab and BcHarash lines, all stably infected with wPip (Wo+), were treated with tetracycline 401 (50 mL/L for larval treatment using a 0.4g/L solution) for 3 generations to create Wolbachia free lines 402 (Wo-: BCTunisTC, SlabTC, BCHarashTC, Table1). Experiments were conducted using the females 403 from: 1) the first generation right after we started the antibiotic treatment, 2) the third generation during 404 the antibiotic treatment to be able to follow the effect of the treatment and 3) from at least three 405 generations after the end of the antibiotic treatment, to exclude the direct effect of TC treatment on host 406 metabolism, and consequently on CpDV quantity and transmission (Wo-).
408
Immunolabelling
409
Immunolabeling were performed on ovaries from 6 days old females and dechorionated eggs. The egg 410 rafts were collected in 1-4 hours following egg laying. The egg-rafts were bleached (active ingredient, 411 9.6% of sodium hypochlorite) to separate the individual eggs and rinsed with distilled water. They were 412 then fixed with 3.2% para-formaldehyde diluted in PBS-T (PBS 1X with Tween 0,02%) for 2 hours, 
416
All the samples were fixed for 1 h in 4% paraformaldehyde (PFA) and washed 3 times with PBS, then 417 treated with 50 mM of NH4Cl for 30 min to minimize autofluorescence. Ovaries and eggs were 418 permeabilized with PBS containing 0.5% Triton and blocking was performed with 1% bovine serum albumin (BSA) in PBS for 1 h. Immunolabelling of CpDV were performed using a mouse primary JcDV 420 anti-capsid antibody that co-reacts with CpDV capsids (Jousset et al., 2000) , diluted at 1:300 in PBS 421 with 0.2% Tween and incubated overnight à 4°C. Secondary antibodies (Alexa Fluor® 488 and 568; 422 1:500; Invitrogen) were used at 1:500 dilutions and incubated for 1 h (ovaries) or 6 h (eggs). Samples 
437
Ultrathin sections were prepared from ovaries of 6 days old females and dechorionated eggs. Dissected 438 ovaries and eggs were first fixed in 2.5% glutaraldehyde in PBS for 2 h at 4°C, and postfixed in 2% 
520
CpDV in females were checked for the first and third generation of tetracycline treatment, they were 521 grouped under during tetracycline treatment group given that these two groups didn't show any 522 significant difference in terms of CpDV amount in the ovaries and represented the same treatment status.
523
A Dunnett's test (glhrt function in multcomp package) (Hothorn et al., 2008) have been performed for 524 pairwise comparison of treatment stages to the non-treated control group.
526
In this model genetic background (Slab, Harash, Tunis) and treatment status (no treatment, during TC 527 treatment and after TC treatment) were fixed effects and different replicates are added as random effects.
528
This last dataset also have been analysed using pairwise Wilcoxon test with Bonferroni correction to 529 compare the different treatment stages to the non-treated control group.
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731
The secondary follicle is composed of undifferentiated cells surrounded by follicular epithelium. The 732 secondary follicle will turn into a primary follicle after oviposition of the oocyte contained in the 733 previous primary follicle (Raikhel and Lea, 1983) . The sheath that enclosed each ovariole is a thin 734 membrane with an outer muscle layer composed of isolated cell bodies interconnected by muscle fibers. 
774
CpDV amount in ovaries (B) Ovaries from three females were dissected and pooled. 5 pools per line 775 have been tested by qPCR assays to quantify CpDV and Wolbachia amount. Mixed effect linear model 776 showed no effect of Wolbachia amount or genetic background on the CpDV amount in the ovaries 777 (Wolbachia amount dev=0.001, df=1, p=0.9, genetic background: dev=1.602, df=2, p= 0.449).
778
Wolbachia strain, however significantly affected the CpDV amount (dev=12.236, df=1, p<0.001).
779
CpDV vertical transmission rate (C) Females from each line were collected 5 days after their blood 780 meal and isolated to lay eggs. Resulting L1 offspring was tested for CpDV prevalence and vertical 
